Lysteda Drug Interactions
Currently displaying a list of 61 drugs known to interact with Lysteda (tranexamic acid).
- 54 major drug interactions
- 6 moderate drug interactions
- 1 minor drug interaction
Medications known to interact with Lysteda
Note: Showing generic names only.
A
- alteplase
- anisindione
- anistreplase
- anti-inhibitor coagulant complex
- antithrombin (recombinant)
- antithrombin iii
- apixaban
- ardeparin
- argatroban
B
C
- carfilzomib
- chlorotrianisene
- coagulation factor Xa
- conjugated estrogens
- conjugated estrogens topical
D
- dabigatran
- dalteparin
- danaparoid
- dehydroepiandrosterone
- desirudin
- dicumarol
- dienestrol topical
- diethylstilbestrol
- drospirenone
E
- edoxaban
- enoxaparin
- esterified estrogens
- estradiol
- estradiol topical
- estramustine
- estrone
- estropipate
- estropipate topical
- ethinyl estradiol
- etonogestrel
F
H
I
L
M
N
O
P
Q
R
S
T
U
W
Lysteda disease interactions
There are 5 disease interactions with Lysteda (tranexamic acid) which include:
- intravascular clotting/thromboembolism
- subarachnoid hemorrhage
- color vision defect
- convulsions
- renal dysfunction
More about Lysteda (tranexamic acid)
- Lysteda consumer information
- Check interactions
- Compare alternatives
- Reviews (70)
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: miscellaneous coagulation modifiers
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.